Evaluation of the Efficacy and Safety of Topical and Oral Glutathione in Treatment of Melasma Med
Most patients begin noticing appetite suppression within the first few weeks, though maximum weight loss typically occurs after several months of treatment
10.1001/jama.298.2.194 Summary Keywords data mining, FAERS, gastrointestinal adverse events, pharmacovigilance, semaglutide Citation Shu Y, He X, Wu P, Liu Y, Ding Y and Zhang Q (2022) Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
To help manage this, try eating smaller, lighter meals and avoid fatty, greasy foods, which can aggravate nausea